Bridgewater Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
Bridgewater Associates's SYNH Position: Q1 2023 in Review
Bridgewater Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 98,086 shares — an estimated $3.6M sold.
Bridgewater Associates first reported a position in SYNH in Q4 2022 and held it in 1 quarter. The position peaked at $3.6M in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.
- Bridgewater Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Bridgewater Associates sold 98,086 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $3.6M.
- Bridgewater Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
- Bridgewater Associates's Syneos Health, Inc. Class A Common Stock position peaked at $3.6M in Q4 2022.
- 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.
Based on Bridgewater Associates's 13F filing for Q1 2023, filed 12 May 2023.